No Picture
Trading Ideas

Exclusive: Novavax executives could get big payday even if vaccine fails

Novavax CEO Stanley Erck and three other executives would earn the options, worth $101 million at Tuesday’s closing stock price, if the company’s vaccine candidate enters a mid-stage clinical trial – regardless of its eventual success, according to a company filing. The incentive plan, which has not been previously reported, allows the executives to start exercising the options a year after Novavax starts the so-called Phase 2 trial, as it expects to do soon. …read more […]

No Picture
Trading Ideas

The Only Way to Protect Yourself From the Fed’s Money Crimes

Up… up… up…
Dow 100,000… here we come.
The Nasdaq and all of its techie components continue to smash records. Amazon (AMZN), Tesla (TSLA) and Facebook (FB) continue their magic trick of turning free money into cold hard cash.
Elon Musk is now the fifth-richest person on the planet, and Jeff Bezos made $13 billion on Monday alone.
Meanwhile… Congress is up against the wall to print more money and mail it to everyday Americans.
With just days to save the nation from eating itself, all eyes are on Washington.
How much money will it print this time?
Another trillion? Maybe three?
Will your neighbor get $600 each …read more […]

No Picture
Trading Ideas

Can remote work growth offset stalls in Microsoft's one-time deals?

Wall Street, however, is braced for Microsoft to report that Azure, its flagship cloud computing business, has slipped below 50% revenue growth for the first time ever. Analysts also expect some declines, such as for Microsoft’s on-premises server purchases and sales of consumer devices. Azure’s slowing growth, analysts said, was long expected as the business balloons to tens of billions of dollars per year. …read more […]

No Picture
Trading Ideas

Tesla’s Elon Musk Qualifies For $2B+ Payout Backed By Share Rally

Tesla Inc.’s (TSLA) billionaire founder Elon Musk qualified on Tuesday for a payout worth more than $2 billion, his second jackpot since May from the electric car maker as the stock surged a whopping 275% this year.Tesla’s stock was down 4.5% at the close on Tuesday, trimming the rally that has propelled the company’s market capitalization to over $290 billion, larger than any other carmaker.Despite Tuesday’s stock decline, Tesla’s six-month average market capitalization for the first time has reached $150 billion, according to a Reuters report. That triggers the vesting of the second of 12 tranches of options granted to …read more […]

No Picture
Trading Ideas

Aurinia Pharma Surges 9% On Priority Review For Lupus Kidney Treatment

Shares in Aurinia Pharma (AUPH) surged 9% in Tuesday’s extended trading after the U.S. Food and Drug Administration (FDA) accepted the filing of its New Drug Application (NDA) for voclosporin, a potential treatment for lupus nephritis (LN). This is a serious inflammation of the kidneys caused by the autoimmune disease systemic lupus erythematosus (SLE).Encouragingly, the FDA granted a faster six-month Priority Review for the application (instead of the usual ten months), with a PDUFA decision date set for January 22, 2021.The FDA also told Aurinia that they are not currently planning to hold an advisory committee meeting to discuss the …read more […]

No Picture
Trading Ideas

Texas Instruments Provides Upbeat Sales Outlook; Top Analyst Sees 18% Upside

Texas Instruments (TXN) sees third-quarter sales beating analysts’ expectations as the work-from-home environment continues to drive demand for the chipmaker’s products for personal computers, tablets and servers.Texas Instruments projects current-quarter revenue will be in a range of $3.26 billion to $3.54 billion, which is above analysts’ expectations of $3.12 billion. Earnings are expected to be in the range of $1.14 to $1.34 a share compared with the 98 cents forecast by an average of analysts.“We will maintain high optionality so we can continue to support customers’ demand, particularly during a time when their ability to forecast may continue to be …read more […]

No Picture
Trading Ideas

OrganiGram Plunges 9% On Soft Top Line; Weak Gross Margins

Shares in cannabis stock OrganiGram (OGI) plunged 9% in Tuesday’s trading after the company reported disappointing earning results for the fiscal third quarter.Specifically, Q3 GAAP EPS of -$0.51 fell short of Street estimates by $0.48. Revenue of $18.02M represented a 27% drop year-over-year, but beat consensus expectations by $2.64M.For the quarter, OGI reported negative gross margin of $26.4 million compared to positive $12.3 million in Q3 2019 citing lower net revenue and higher cost of sales.Meanwhile the company announced that it reduced its workforce by ~25% or ~220 employees in June 2020 in order to ‘better align with the needs …read more […]

No Picture
Trading Ideas

European Stocks Drop While Gold, Silver Rally: Markets Wrap

(Bloomberg) — European stocks dropped and U.S. futures fluctuated after the White House delivered fresh warnings about the spread of the coronavirus and as uncertainty lingered over the timing of new stimulus.The dollar fell for a fourth day as President Donald Trump warned the outbreak will probably get worse before it gets better. Gold jumped above $1,850 an ounce, while silver climbed to the highest in almost seven years. Oil in New York eased from a four-month high on signs of a surprise gain in U.S. crude stockpiles. Asian shares traded mixed.As earnings continue to roll in, investors are taking …read more […]

No Picture
Trading Ideas

Intuitive Surgical Delivers Strong Quarter; But Analyst Says Sell Now

Intuitive Surgical (ISRG) has delivered another strong quarter driven by better-than-expected system placements and procedure volume. Shares in the robotic surgery company rose 2% in Tuesday’s after-hours trading, with the stock now up 11% year-to-date.Second quarter Non-GAAP EPS of $1.11 beat Street estimates by $0.62 while revenue of $852.1M beat forecasts by $215.26M, despite falling 22% year-over-year. Also encouraging was the number of the company’s daVinci systems shipped at 178 (down 3.5% year-over-year), versus the Street’s estimated 141. Procedure volume declined by 19% year-over-year, but was nevertheless an improvement on the consensus estimate of 29%.However, GAAP EPS of $0.57 missed …read more […]

No Picture
Trading Ideas

Snap Drops 6% In Extended Trading As User Growth Disappoints; Top Analyst Lifts PT

Shares in Snap Inc. (SNAP) dropped over 6% in extended market trading after its second-quarter loss widened and user growth figures disappointed.The stock declined to $23.17 in Tuesday’s after-market trading. Snap reported a net loss of $326 million, or 23 cents per share, in the quarter ended June, widening from $255.2 million, or 19 cents per share, in the year-earlier period. Meanwhile, total revenue increased 17% to $454 million during the reported period.Daily active users (DAUs), a widely followed metric by investors and advertisers, increased 17% to 238 million in the second quarter year-on-year but fell short of analysts’ expectations …read more […]